Literature DB >> 3415367

Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies.

M A Khamashta1, A Gil, B Anciones, P Lavilla, M E Valencia, V Pintado, J J Vázquez.   

Abstract

Chorea is a rare manifestation of systemic lupus erythematosus (SLE). In this report the clinical features of two cases of chorea associated with SLE are presented. Of special interest were the raised titres of antiphospholipid antibodies in both cases. The possible pathogenic role of these antibodies is briefly discussed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3415367      PMCID： PMC1006722          DOI： 10.1136/ard.47.8.681

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  11 in total

1.  Clinical features of chorea associated with systemic lupus erythematosus.

Authors:  J O Lusins; P A Szilagyi
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

2.  Chorea and the lupus anticoagulant.

Authors:  J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

3.  Chorea minor associated with systemic lupus erythematosus. Report of a case.

Authors:  J E Olsen
Journal:  Acta Med Scand       Date:  1968 Jan-Feb

4.  Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report.

Authors:  W F Lubbe; E B Walker
Journal:  Br J Obstet Gynaecol       Date:  1983-05

5.  Collagen vascular disease appearing as chorea gravidarum.

Authors:  B L Agrawal; R P Foa
Journal:  Arch Neurol       Date:  1982-03

6.  Nervous system involvement in systemic lupus erythematosus.

Authors:  T Gibson; A R Myers
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

7.  Chorea as an initial manifestation of systemic lupus erythematosus. A case report of a 10-year-old girl.

Authors:  O Arisaka; K Obinata; H Sasaki; M Arisaka; K Kaneko
Journal:  Clin Pediatr (Phila)       Date:  1984-05       Impact factor: 1.168

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  [Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases].

Authors:  B Bouchez; G Arnott; P Y Hatron; A Wattel; B Devulder
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

10.  Systemic lupus erythematosus presenting as chorea.

Authors:  L F Kukla; C Reddy; G Silkalns; M Prasad
Journal:  Arch Dis Child       Date:  1978-04       Impact factor: 3.791
View more
  25 in total

1.  An unusual cause of hemichorea-hemiballism in a patient with systemic lupus erythematosus.

Authors:  Akihito Maruyama; Takao Nagashima; Yasuyuki Kamata; Katsuya Nagatani; Takamasa Murosaki; Taku Yoshio; Seiji Minota
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

2.  Antiphospholipid antibodies: which and when?

Authors:  R Cervera; J Font; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

3.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

4.  Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.

Authors:  Simone Appenzeller; Steeven Yeh; Marcelo Maruyama; Solange Murta Barros; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

5.  Disseminated zygomycosis and systemic lupus erythematosus.

Authors:  C A Bloxham; S Carr; D W Ryan; P J Kesteven; R S Bexton; I D Griffiths; J Richards
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 6.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 7.  Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Authors:  M A Khamashta; G R Hughes
Journal:  Clin Rev Allergy       Date:  1994

8.  Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.

Authors:  L Ziporen; Y Shoenfeld; Y Levy; A D Korczyn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

Review 9.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

10.  Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study.

Authors:  G D Sebastiani; G Passiu; M Galeazzi; F Porzio; U Carcassi
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.